Vipin Kumar

Vipin Kumar

Auto-generated profile, based on publicly available information

Vipin Kumar

Broad Institute of MIT and Harvard, Cambridge, USA

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2022 in Genome Biology
Verified
Journal Article
Open access
PDF file
RRRoberto Rossini
Roberto Rossini
VKVipin Kumar
Vipin Kumar
AMAnthony Mathelier
Anthony Mathelier
TRTorbjørn Rognes
Torbjørn Rognes
JPJonas Paulsen
Jonas Paulsen
DNA loop extrusion emerges as a key process establishing genome structure and function. We introduce MoDLE, a computational tool for fast, stochastic modeling of molecular contacts from DNA loop extrusion capable of simulating realistic contact patterns genome wide in a few minutes. MoDLE accurately simulates contact maps in concordance with existing molecular dynamics approaches and with Micro-C data and does so orders of magnitude faster than existing approaches. MoDLE runs efficiently on machines ranging from laptops to high performance computing clusters and opens up for exploratory and predictive modeling of 3D genome structure in a wide range of settings.

3 April 2025 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
CHChenlei Hu
Chenlei Hu
MBMehdi Borji
Mehdi Borji
GMGiovanni J. Marrero
Giovanni J. Marrero
VKVipin Kumar
Vipin Kumar
JWJackson A. Weir
Jackson A. Weir
FCFei Chen
Fei Chen

21 January 2026 in Nature
Verified
Journal Article
Closed access
PDF file
SWSherry Jingjing Wu
Sherry Jingjing Wu
MDMin Dai
Min Dai
SYShang-Po Yang
Shang-Po Yang
CMCai McCann
Cai McCann
YQYanjie Qiu
Yanjie Qiu
GFGord Fishell
Gord Fishell

1 December 1991 in Current Opinion in Immunology
Verified
Journal Article
Closed access
VKVipin Kumar
Vipin Kumar
ESEli E. Sercarz
Eli E. Sercarz

22 July 2026 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
ANAdi Nagler
Adi Nagler
ASAmit Sud
Amit Sud
JGJack Yacoub Ghannam
Jack Yacoub Ghannam
LPLucas Pomerance
Lucas Pomerance
CRCamila Robles-Oteiza
Camila Robles-Oteiza
CWCatherine J. Wu
Catherine J. Wu

29 March 2025 in Asian Journal of Chemistry
Verified
Journal Article
Open access
PDF file
KRKailash Rani
Kailash Rani
VKVipin Kumar
Vipin Kumar
RSRakesh K Sindhu
Rakesh K Sindhu
SMSomdutt Mujwar
Somdutt Mujwar
Tubulin is an essential protein involved in microtubule dynamics that regulate mitotic cell division in normal cells. Specifically, the colchicine-binding site of tubulin serves as a therapeutic target to disrupt microtubule dynamics, inducing mitotic arrest and leading to cell death. In current study, we synthesized methoxy and fluorine substituted novel chalcones (4a-o) and the synthesized chalcone compounds showed promising anticancer activity by in vitro cell viability using the MTT assay in the lung cancer (A549) and breast cancer (MCF-7) cell lines and in silico docking simulations along with optimization of drug-like and pharmacokinetic properties. Among all compounds, (E)-1-(4,6-dimethoxybenzofuran-2-yl)-3-(4-methoxyphenyl)prop-2-en-1-one (4f) had the highest potency (IC50 = 23.9 ± 0.203 µM), followed by the fluorine substituted compound (E)-1-(4,6-dimethoxybenzofuran-2-yl)-3-(2,4,6-trifluorophenyl)prop-2-en-1-one (4m) (IC50 value of 35.44 µM). Moreover, compound 4f demonstrated an excellent docking interaction (-9.94 kcal/mol) with the key residues Met-259, Leu-255 and Ala-250 at colchicine-binding pocket of tubulin against millepachine, which is similar to the millepachine binding site of tubulin, suggesting a mechanism of action that may potentially affect microtubule dynamics. Additionally, compound 4f identified promising drug-like properties, physico-chemical and pharmacokinetic characteristics.